Narsoplimab is a human monoclonal antibody that specifically targets mannan-binding lectin-associated serine protease-2. The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) ...

Omeros Corporation, an innovative biotechnology company, announced that the US Food and Drug Administration (FDA) has approved Yartemlea (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

Up to 1,000 additional blood platelet donors are needed in the coming year to meet demand. The Irish Blood Transfusion Service (IBTS) has said there are currently 2,000 regular donors who supply ...

Omeros Corporation OMER recently announced that the FDA approved its YARTEMLEA (narsoplimab-wuug) to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA), a frequent ...

You may need an MPV test if you show symptoms that suggest an issue with your platelet size or number. An MPV test involves drawing a blood sample from a vein and typically takes less than five ...